pJSC173 - Bacterial expression plasmid for SpCas9 Cluster 1 (HypaCas9) variant Citations (2)

Originally described in: Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA Nature. 2017 Sep 20. doi: 10.1038/nature24268. PubMed Journal

---

Articles Citing pJSC173 - Bacterial expression plasmid for SpCas9 Cluster 1 (HypaCas9) variant

Articles
Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants. Murugan K, Suresh SK, Seetharam AS, Severin AJ, Sashital DG. Nucleic Acids Res. 2021 Apr 19;49(7):4037-4053. doi: 10.1093/nar/gkab163. PubMed
Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis. Bak SY, Jung Y, Park J, Sung K, Jang HK, Bae S, Kim SK. Nucleic Acids Res. 2021 Nov 8;49(19):11312-11322. doi: 10.1093/nar/gkab858. PubMed

If you have published an article using this material, please email us at to have your article added to this page.